Search filters

List of works by Justyna Janocha-Litwin

DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.

scientific article

Diagnostic challenges in primary hepatocellular carcinoma: case reports and review of the literature

scientific article

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19

scientific article published on 8 March 2021

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)

HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)

scientific article published on 22 March 2023

Manganese Encephalopathy among Ephedron Abusers.

scientific article published on 26 September 2014

Neurological complications of SARS-CoV-2 infection in a 66-year-old man

scientific article published on 11 August 2020

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

scientific article published on 13 January 2022

Rapid progression of lung inflammatory infiltrates in SARS-CoV-2 infection in a young man

scientific article published on 08 April 2020

Recurrent meningitis--a review of current literature

scientific article published on January 2013

The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin

scientific article published on 28 November 2016

The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin

scientific article published on 18 January 2021

The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin